Brief: Sedana Medical Q2 EBIT Margin at -44%
21/07/2023 06:16
Jul 21 (Reuters) - Sedana Medical Q2 cash flow from operating activities SEK -36 million. * Q2 adjusted EPS SEK 0.01 * Q2 net income SEK 1.4 million * Q2 sales SEK 37.3 million * Q2 EBIT margin -44% * Q2 EBITDA SEK -10.7 million
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln